Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Role of Astrocytes in Multiple Sclerosis Progression.
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.
"Nine" syndrome: A new neuro-ophthalmologic syndrome: Report of two cases.
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1a therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).
[Future issues of the multiple sclerosis treatment from a medical economic viewpoint].
Care Partners and Multiple Sclerosis: Differential Effect on Men and Women.
Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report.
A spring to summer shift of pro-inflammatory cytokine production in multiple sclerosis patients.
Similar barriers and facilitators to physical activity across different clinical groups experiencing lower limb spasticity.
Interferon-β Modulates Inflammatory Response in Cerebral Ischemia.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Mortality following a brain tumour diagnosis in patients with multiple sclerosis.
Acute neuronal apoptosis in a rat model of multiple sclerosis.
[Extending therapeutic possibilities in relapsing-remitting multiple sclerosis: dimethyl fumarate].
Peptide immunotherapy in experimental autoimmune encephalomyelitis.
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.
Development and implementation of microsimulation models of neurological conditions.
Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, chol
Erratum to: Reassessing the risk of natalizumab-associated PML.
Promoting peripheral myelin repair.
Does the preclinical evidence for functional remyelination following engraftment into the injured spinal cord support progression to clinical trials?
Auditory deficits in neurological disorders.
Importance of Apolipoprotein A-I in Multiple Sclerosis.
Medical use of cannabis products : Lessons to be learned from Israel and Canada.
Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple Levels.
Pages
« first
‹ previous
…
680
681
682
683
684
685
686
687
688
…
next ›
last »